tiprankstipranks
Heron Therapeutics (HRTX)
NASDAQ:HRTX

Heron Therapeutics (HRTX) Stock Investors

1,411 Followers
Based on 728,053 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold HRTX
On average, investors allocate 3.66% of their portfolios to HRTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 728,053 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding HRTX

1.4%
Last 7
Days
0.4%
Last 30
Days
Percentages indicate the change in the number of portfolios holding HRTX, out of 728,053 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

HRTX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.00%
$2.88
Opened
0.23%
$2.63
Increased
21.84%
$2.71
Opened
1.37%
$3.06
Based on the activity of 13,680 investors who made their portfolios public
The table shows changes in HRTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

HRTX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
GE Aerospace
5.50%
+0.70%
+5.35%
168.04B
Industrials
Block
4.49%
-1.25%
-6.79%
45.25B
Technology
Micron
5.83%
+0.42%
+26.38%
134.40B
Technology
Oracle
4.32%
+0.45%
+2.04%
329.49B
Technology
Shopify
5.62%
-0.60%
-5.25%
88.05B
Technology
Qualcomm
4.84%
-0.95%
-4.83%
189.54B
Technology
International Business Machines
5.73%
+1.39%
+1.99%
166.16B
Technology
Mastercard
4.77%
-0.18%
-1.76%
428.93B
Financial
DraftKings
7.13%
-1.06%
-3.36%
37.89B
Consumer Cyclical
Salesforce
4.90%
+1.29%
-0.87%
264.71B
Technology
Based on the activity of 728,053 active portfolios
Open your Smart Portfolio

HRTX Investor Analysis

HRTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.7%
of HRTX holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
HRTX investors between 35–55

Between 35–55

3.6%
Last 30 days
Holdings Change
53.8%
of HRTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
HRTX investors over 55

Over 55

12.4%
Last 30 days
Holdings Change
36.6%
of HRTX holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of HRTX stock investors
See who invests in HRTX according to age group and performance.

FAQ

How many retail Investors hold HRTX?
<0.1% of TipRanks' retail investors hold HRTX in their portfolios.
    What is HRTX Investor Sentiment?
    HRTX’s Investor Sentiment is Negative.
      What percentage of retail investors changed their holding of HRTX in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of HRTX in the last 7 days.
        What percentage of retail investors changed their holding of HRTX in the last 30 days?
        ▲ 0.4% of TipRanks' retail investors changed their holding of HRTX in the last 30 days.
          What is the average age of retail investors who hold HRTX?
          The average age of HRTX Holders is between 35–55.
            What other stocks have HRTX investors also bought?
            HRTX Investors also bought GE, SQ, MU, ORCL, SHOP, QCOM, IBM, MA, DKNG, CRM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis